Analysis: Experts split on DTC drug ads
This article addresses the current debate about "Direct to Consumer" drug ads.
Some advocate banning the ads which they say do more harm than good; others claim the ads may need more stringent regulating but on the whole are helpful.
The concern is that in some cases such as with vioxx, marketing proceeds before safety issues are fully established. 
· Read The Full Arthritis Care Article From United Press International -->
·
Read All Arthritis Care News Stories -->